Children and adults with rare, deadly genetic diseases have fresh hope for curative therapies, thanks to a new collaboration between the Innovative Genomics Institute (IGI) and Danaher Corporation, a ...

Over the last decade, RNAi-based loss-of-function screens have proven to be an effective tool to identify essential genes and critical genetic drivers for a host of responses as well as potential drug ...

The practice of genetic modification is as old as humanity. For thousands of years, humans have bred crops, livestock and even pets that possess desirable traits. This selective process, which alters ...

For some years now, RNAi has been the workhorse of genomic screening projects. While the plenty of investigators have slogged through experiments and data using RNAi—with an array of useful data ...